🔗 Share this article

The Nobel Prize in Physiology or Medicine has been awarded for transformative findings that clarify how the body's defense network attacks dangerous infections while protecting the healthy tissues.

A trio of renowned scientists—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this accolade.

The research identified specialized "sentinels" within the immune system that eliminate rogue immune cells capable of attacking the organism.

The discoveries are now paving the way for innovative treatments for immune disorders and cancer.

The winners will share a prize fund valued at 11 million Swedish kronor.

Crucial Findings

"The research has been decisive for understanding how the body's defenses operates and why we do not all develop serious autoimmune diseases," stated the head of the award panel.

This trio's research address a core question: In what way does the immune system protect us from numerous infections while keeping our own tissues unharmed?

Our immune system employs white blood cells that search for signs of infection, including pathogens and bacteria it has never encountered.

Such cells utilize sensors—called recognition units—that are produced randomly in a vast number of variations.

That provides the defense network the ability to fight a wide array of threats, but the randomness of the mechanism inevitably creates immune cells that may target the host.

Security Guards of the Body

Scientists earlier knew that a portion of these problematic defense cells were eliminated in the immune organ—the site where immune cells develop.

The latest award honors the identification of T-reg cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize any defenders that assault the body's own tissues.

We know that this mechanism fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The prize committee stated, "These findings have laid the foundation for a novel area of investigation and accelerated the creation of new treatments, for instance for cancer and immune disorders."

Regarding cancer, T-regs block the system from attacking the growth, so studies are focused on lowering their quantity.

In autoimmune diseases, trials are exploring increasing regulatory T-cells so the body is no longer being harmed. A comparable approach could also be effective in reducing the chances of transplanted organ rejection.

Innovative Experiments

Professor Shimon Sakaguchi, of a Japanese institution, performed tests on mice that had their immune gland removed, leading to self-attack conditions.

He showed that injecting defense cells from healthy mice could stop the disease—implying there was a mechanism for preventing defenders from harming the body.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an inherited autoimmune disease in mice and humans that resulted in the identification of a gene vital for the way T-regs function.

"Their groundbreaking work has revealed how the immune system is controlled by regulatory T cells, stopping it from mistakenly targeting the body's own tissues," said a leading biological science specialist.

"The work is a remarkable example of how basic biological study can have broad implications for public health."